Orchard Therapeutics competitorsClear all

Affinia Therapeutics's top competitors include AID Genomics, Annexon Biosciences and Oxford BioTherapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Affinia Therapeutics
Affinia Therapeutics
Affinia Therapeutics is a biotech company.
AID Genomics
AID Genomics
AID Genomics is a group of medical technology companies specializing in the diagnosis and therapy of cancer.
Annexon Biosciences
Annexon Biosciences
Annexon Biosciences is leading the development of therapeutic products that halt the progression of complement-mediated neurodegeneration.
Oxford BioTherapeutics
Oxford BioTherapeutics
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
Founding Date
Founding Date
2019
Founding Date
2013
Founding Date
2011
Founding Date
2004
Type
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Waltham, US HQ
Locations
Rehovot, IL HQ
Locations
South San Francisco, US HQ
Locations
Milton, GB HQ
San Jose, US
Employees
Employees
605% increase
Employees
4211% increase
Employees
574% increase
Employees
28

Funding

Latest funding round
Latest funding round
$ 60m (over 1 year ago)
Latest funding round
N/A
Latest funding round
$ 100m (about 1 year ago)
Latest funding round
$ 10m (about 6 years ago)
Total funding raised
Total funding raised
$ 60m
Total funding raised
N/A
Total funding raised
$ 179m
Total funding raised
$ 21.6m
For sources of this data, please see the company profile

View company profiles

AID Genomics
HQ
Rehovot, IL
Employees
42↑ 11% increase

AID Genomics is a group of medical technology companies specializing in the diagnosis and therapy of cancer.

View company
Annexon Biosciences
HQ
South San Francisco, US
Employees
57↑ 4% increase

Annexon Biosciences is leading the development of therapeutic products that halt the progression of complement-mediated neurodegeneration.

View company
Oxford BioTherapeutics
HQ
Milton, GB
Employees
28

Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.

View company